The US Food and Drug
Administration (FDA) has approved
Topamax (topiramate) for migraine
prevention in adolescents aged 12
to 17 years of age.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 01 Apr 14 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 Apr 14
PROMPTED by yet another emergency situation threatening medicines access for patients, namely the tragic Townsville floods, the Pharmacy Guild of Australia has called for three key changes around medicines supply to consumers.